Evidence map›Paper›PMID 12083417›Full record

ArticleInflammation2002

Functional effects of eotaxin are selectively upregulated on IL-5 transgenic mouse eosinophils.

Elizabeth Kudlacz, Carrie Whitney, Catharine Andresenl, Maryrose Conklyn

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Elizabeth KudlaczPfizer Global Research and Development, Groton, CT 06340, USA. elizabeth_m_kudlacz@groton.pfizer.com
Carrie Whitney
Catharine Andresenl
Maryrose Conklyn
Pfizer (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Synergistic interactions between cytokines, chemokines and adhesion molecules may facilitate the selective recruitment of eosinophils into sites of allergic inflammation. Ovalbumin-sensitized IL5TG mice responded to antigen challenge with robust airway eosinophilia 24 and 72 hr post-exposure. Adhesion molecule expression and functional responsiveness of immune cells derived from IL5TG mice to various inflammatory mediators were evaluated. IL5TG-derived eosinophils, but not neutrophils, expressed higher levels of CD49d and CD11b relative to WT. Functional responsiveness to eotaxin was increased in IL5TG eosinophils as demonstrated by a 10x increase in its potency in producing actin polymerization and 3x increase in CD11b upregulation relative to WT. These data are consistent with increased CCR3 expression on IL5TG eosinophils. Responsiveness of eosinophils to LTB4 or MIP-1alpha was similar between WT and IL-5TG mice. These data provide evidence of synergy between eosinophil-specific cytokines and chemokines that may promote accumulation of this cell type under conditions of allergic inflammation in vivo.

Indexed as

Adjuvants, ImmunologicAnimalsAsthmaBronchoalveolar Lavage FluidCell Adhesion MoleculesChemokine CCL11Chemokines, CCChemotactic Factors, EosinophilChemotaxis, LeukocyteDisease Models, AnimalDrug SynergismEosinophilsIntegrin alpha4Interleukin-5MiceMice, TransgenicAdjuvants, ImmunologicCcl11 protein, mouseCcr3 protein, mouseCell Adhesion MoleculesChemokine CCL11Chemokines, CCChemotactic Factors, EosinophilIntegrin alpha4Interleukin-5Receptors, CCR3Receptors, Chemokine

Identifiers

PMID12083417
OpenAlexW24520786

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.